Xiang-Yang Ye

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 35

Top Venues

Journal of medicinal chemistry

Expert opinion on therapeutic patents

Molecules (Basel, Switzerland)

Organic & biomolecular chemistry

Hangzhou Normal University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Hangzhou Normal University Dec 01 2018

China

Professor :: School of Medicine

Bristol-Myers Squibb Sep 01 2002 - Dec 31 2016

United States

Principal Scientist :: Research & Development

Publications

Bo-Wen Sun, Peng-Peng Zhang, Zong-Hao Wang, Xia Yao, Meng-Lan He, Rui-Ting Bai, Hao Che, Jing Lin, Tian Xie, Zi Hui, Xiang-Yang Ye, Li-Wei Wang
Prevention and Potential Treatment Strategies for Respiratory Syncytial Virus. Molecules (Basel, Switzerland) 29 (3) (2024)
Yuan Gao, Ji-Long Duan, Chen-Chen Wang, Yinghui Yuan, Pengpeng Zhang, Zong-Hao Wang, Bowen Sun, Jiawei Zhou, Xiaoli Du, Xiawen Dang, Rui-Ting Bai, Hang Zhang, Tian Xie, Xiang-Yang Ye
Novel Bifunctional Conjugates Targeting PD-L1/PARP7 as Dual Immunotherapy for Potential Cancer Treatment. Journal of medicinal chemistry (2024)
Ji-Long Duan, Chen-Chen Wang, Yinghui Yuan, Zi Hui, Hang Zhang, Nian-Dong Mao, Pengpeng Zhang, Bowen Sun, Jing Lin, Zishuo Zhang, Yuan Gao, Tian Xie, Xiang-Yang Ye
Design, Synthesis, and Structure-Activity Relationship of Novel Pyridazinone-Based PARP7/HDACs Dual Inhibitors for Elucidating the Relationship between Antitumor Immunity and HDACs Inhibition. Journal of medicinal chemistry 67 (6) (2024)
Ji-Long Duan, Chen-Chen Wang, Yinghui Yuan, Zi Hui, Hang Zhang, Nian-Dong Mao, Pengpeng Zhang, Bowen Sun, Jing Lin, Zishuo Zhang, Yuan Gao, Tian Xie, Xiang-Yang Ye
Design, Synthesis, and Structure-Activity Relationship of Novel Pyridazinone-Based PARP7/HDACs Dual Inhibitors for Elucidating the Relationship between Antitumor Immunity and HDACs Inhibition. Journal of medicinal chemistry (2024)
Yuan Gao, Ji-Long Duan, Chen-Chen Wang, Yinghui Yuan, Pengpeng Zhang, Zong-Hao Wang, Bowen Sun, Jiawei Zhou, Xiaoli Du, Xiawen Dang, Rui-Ting Bai, Hang Zhang, Tian Xie, Xiang-Yang Ye
Novel Bifunctional Conjugates Targeting PD-L1/PARP7 as Dual Immunotherapy for Potential Cancer Treatment. Journal of medicinal chemistry 67 (13) (2024)
Yuan Gao, Ji-Long Duan, Chen-Chen Wang, Yinghui Yuan, Pengpeng Zhang, Zong-Hao Wang, Bowen Sun, Jiawei Zhou, Xiaoli Du, Xiawen Dang, Rui-Ting Bai, Hang Zhang, Tian Xie, Xiang-Yang Ye
Novel Bifunctional Conjugates Targeting PD-L1/PARP7 as Dual Immunotherapy for Potential Cancer Treatment. Journal of medicinal chemistry 67 (13) (2024)
Bo-Wen Sun, Peng-Peng Zhang, Zong-Hao Wang, Xia Yao, Meng-Lan He, Rui-Ting Bai, Hao Che, Jing Lin, Tian Xie, Zi Hui, Xiang-Yang Ye, Li-Wei Wang
Prevention and Potential Treatment Strategies for Respiratory Syncytial Virus. Molecules (Basel, Switzerland) 29 (3) (2024)
Ji-Long Duan, Chen-Chen Wang, Yinghui Yuan, Zi Hui, Hang Zhang, Nian-Dong Mao, Pengpeng Zhang, Bowen Sun, Jing Lin, Zishuo Zhang, Yuan Gao, Tian Xie, Xiang-Yang Ye
Design, Synthesis, and Structure-Activity Relationship of Novel Pyridazinone-Based PARP7/HDACs Dual Inhibitors for Elucidating the Relationship between Antitumor Immunity and HDACs Inhibition. Journal of medicinal chemistry 67 (6) (2024)
Bo-Wen Sun, Peng-Peng Zhang, Zong-Hao Wang, Xia Yao, Meng-Lan He, Rui-Ting Bai, Hao Che, Jing Lin, Tian Xie, Zi Hui, Xiang-Yang Ye, Li-Wei Wang
Prevention and Potential Treatment Strategies for Respiratory Syncytial Virus. Molecules (Basel, Switzerland) 29 (3) (2024)
Bo-Wen Sun, Peng-Peng Zhang, Zong-Hao Wang, Xia Yao, Meng-Lan He, Rui-Ting Bai, Hao Che, Jing Lin, Tian Xie, Zi Hui, Xiang-Yang Ye, Li-Wei Wang
Prevention and Potential Treatment Strategies for Respiratory Syncytial Virus. Molecules (Basel, Switzerland) 29 (3) (2024)
Bo-Wen Sun, Peng-Peng Zhang, Zong-Hao Wang, Xia Yao, Meng-Lan He, Rui-Ting Bai, Hao Che, Jing Lin, Tian Xie, Zi Hui, Xiang-Yang Ye, Li-Wei Wang
Prevention and Potential Treatment Strategies for Respiratory Syncytial Virus. Molecules (Basel, Switzerland) 29 (3) (2024)
Jinyun Dong, Jilong Duan, Zi Hui, Carmen Garrido, Zhangshuang Deng, Tian Xie, Xiang-Yang Ye
An updated patent review of protein arginine N-methyltransferase inhibitors (2019-2022). Expert opinion on therapeutic patents (2023)
Haowen Deng, Jianshe Wang, Wei He, Yang Ye, Renren Bai, Xuelei Zhang, Xiang-Yang Ye, Tian Xie, Zi Hui
Microwave-assisted rapid synthesis of chiral oxazolines. Organic & biomolecular chemistry 21 (11) (2023)
Bing Xu, Huan Xiang, Yuqiong Tan, Ze Li, Shijun Li, Xiang-Yang Ye, Yang Ye
Alkenyl Thioetherification Enabled by Nickel Catalysis. The Journal of organic chemistry (2023)
Haowen Deng, Jianshe Wang, Wei He, Yang Ye, Renren Bai, Xuelei Zhang, Xiang-Yang Ye, Tian Xie, Zi Hui
Microwave-assisted rapid synthesis of chiral oxazolines. Organic & biomolecular chemistry (2023)
Jinyun Dong, Jilong Duan, Zi Hui, Carmen Garrido, Zhangshuang Deng, Tian Xie, Xiang-Yang Ye
An updated patent review of protein arginine N-methyltransferase inhibitors (2019-2022). Expert opinion on therapeutic patents 32 (12) (2023)
Jinyun Dong, Jilong Duan, Zi Hui, Carmen Garrido, Zhangshuang Deng, Tian Xie, Xiang-Yang Ye
An updated patent review of protein arginine N-methyltransferase inhibitors (2019-2022). Expert opinion on therapeutic patents 32 (12) (2023)
Jinyun Dong, Jilong Duan, Zi Hui, Carmen Garrido, Zhangshuang Deng, Tian Xie, Xiang-Yang Ye
An updated patent review of protein arginine N-methyltransferase inhibitors (2019-2022). Expert opinion on therapeutic patents 32 (12) (2023)
Xiaoying Jiang, Kaiyu Wu, Xiang-Yang Ye, Tian Xie, Pengfei Zhang, Benjamin E Blass, Renren Bai
Novel druggable mechanism of Parkinson's disease: Potential therapeutics and underlying pathogenesis based on ferroptosis. Medicinal research reviews (2023)
Yuan Gao, Nian-Dong Mao, Hao Che, Li Xu, Renren Bai, Li-Wei Wang, Xiang-Yang Ye, Tian Xie
Novel hydroxyl carboximates derived from β -elemene: design, synthesis and anti-tumour activities evaluation. Journal of enzyme inhibition and medicinal chemistry 37 (1) (2022)
Yang Ye, Ying Lin, Nian-Dong Mao, Huimin Yang, Xiang-Yang Ye, Tian Xie
Recent progress in nickel-catalyzed carboboration of alkenes. Organic & biomolecular chemistry 20 (47) (2022)
Yang Ye, Xiang Qi, Bing Xu, Ying Lin, Huan Xiang, Liang Zou, Xiang-Yang Ye, Tian Xie
Nickel-catalyzed cross-electrophile allylation of vinyl bromides and the modification of anti-tumour natural medicine β-elemene. Chemical science 13 (23) (2022)
Renren Bai, Junlong Zhu, Ziqiang Bai, Qing Mao, Yingqian Zhang, Zi Hui, Xinyu Luo, Xiang-Yang Ye, Tian Xie
Second generation β-elemene nitric oxide derivatives with reasonable linkers: potential hybrids against malignant brain glioma. Journal of enzyme inhibition and medicinal chemistry 37 (1) (2022)
Maeva Wendremaire, Tatiana E Lopez, Marina Barrichon, Hang Zhang, Tarik Hadi, Xiang-Yang Ye, Fabrice Neiers, Marc Bardou, Paul Sagot, Carmen Garrido, Frédéric Lirussi
Leptin-Induced HLA-G Inhibits Myometrial Contraction and Differentiation. Cells 11 (6) (2022)
Suwen Hu, Zi Hui, Jilong Duan, Carmen Garrido, Tian Xie, Xiang-Yang Ye
Discovery of small-molecule ATR inhibitors for potential cancer treatment: a patent review from 2014 to present. Expert opinion on therapeutic patents 32 (4) (2022)
Li-Wei Wang, Songwei Jiang, Ying-Hui Yuan, Jilong Duan, Nian-Dong Mao, Zi Hui, Renren Bai, Tian Xie, Xiang-Yang Ye
Recent Advances in Synergistic Antitumor Effects Exploited from the Inhibition of Ataxia Telangiectasia and RAD3-Related Protein Kinase (ATR). Molecules (Basel, Switzerland) 27 (8) (2022)
Han Zou, Tingyue Wu, Yuan Wang, Yanhua Kang, Qingye Shan, Liqing Xu, Zheyi Jiang, Xiaohan Lin, Xiang-Yang Ye, Tian Xie, Martin E Schimpf
5-Hydroxymethylfurfural Enhances the Antiviral Immune Response in Macrophages through the Modulation of RIG-I-Mediated Interferon Production and the JAK/STAT Signaling Pathway. ACS omega 6 (42) (2021)
Suwen Hu, Zi Hui, Frederic Lirussi, Carmen Garrido, Xiang-Yang Ye, Tian Xie
Small molecule DNA-PK inhibitors as potential cancer therapy: a patent review (2010-present). Expert opinion on therapeutic patents 31 (5) (2021)
Yang Ye, Jiandong Liu, Bing Xu, Songwei Jiang, Renren Bai, Shijun Li, Tian Xie, Xiang-Yang Ye
Nickel-catalyzed enantioselective 1,2-vinylboration of styrenes. Chemical science 12 (39) (2021)
Bing Xu, Ying Lin, Yang Ye, Li Xu, Tian Xie, Xiang-Yang Ye
Benzyl thioether formation merging copper catalysis. RSC advances 12 (2) (2021)
Suwen Hu, Songwei Jiang, Xiang Qi, Renren Bai, Xiang-Yang Ye, Tian Xie
Races of small molecule clinical trials for the treatment of COVID-19: An up-to-date comprehensive review. Drug development research (2021)
Xingrui He, Xiao-Tao Zhuo, Yuan Gao, Renren Bai, Xiang-Yang Ye, Tian Xie
β-Elemene derivatives produced from SeO2-mediated oxidation reaction. Royal Society open science 7 (5) (2020)
Xingrui He, Xiabin Chen, Hancheng Zhang, Tian Xie, Xiang-Yang Ye
Selective Tyk2 inhibitors as potential therapeutic agents: a patent review (2015-2018). Expert opinion on therapeutic patents 29 (2) (2019)
Xiang-Yang Ye, Stephanie Y Chen, Shung Wu, David S Yoon, Haixia Wang, Zhenqiu Hong, Stephen P O'Connor, Jun Li, James J Li, Lawrence J Kennedy, Steven J Walker, Akbar Nayeem, Steven Sheriff, Daniel M Camac, Vidyhashankar Ramamurthy, Paul E Morin, Rachel Zebo, Joseph R Taylor, Nathan N Morgan, Randolph P Ponticiello, Thomas Harrity, Atsu Apedo, Rajasree Golla, Ramakrishna Seethala, Mengmeng Wang, Timothy W Harper, Bogdan G Sleczka, Bin He, Mark Kirby, David K Leahy, Jianqing Li, Ronald L Hanson, Zhiwei Guo, Yi-Xin Li, John D DiMarco, Raymond Scaringe, Brad D Maxwell, Frederick Moulin, Joel C Barrish, David A Gordon, Jeffrey A Robl
Discovery of Clinical Candidate 2-((2S,6S)-2-Phenyl-6-hydroxyadamantan-2-yl)-1-(3'-hydroxyazetidin-1-yl)ethanone [BMS-816336], an Orally Active Novel Selective 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor. Journal of medicinal chemistry 60 (12) (2017)
Joseph E Carpenter, Ying Wang, Gang Wu, Jianxin Feng, Xiang-Yang Ye, Christian L Morales, Matthias Broekema, Karen A Rossi, Keith J Miller, Brian J Murphy, Ginger Wu, Sarah E Malmstrom, Anthony V Azzara, Philip M Sher, John M Fevig, Andrew Alt, Robert L Bertekap, Mary Jane Cullen, Timothy M Harper, Kimberly Foster, Emily Luk, Qian Xiang, Mary F Grubb, Jeffrey A Robl, Dean A Wacker
Utilization of an Active Site Mutant Receptor for the Identification of Potent and Selective Atypical 5-HT2C Receptor Agonists. Journal of medicinal chemistry 60 (14) (2017)

Xiang-Yang Ye.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Xiang-Yang Ye